glp 1 receptors PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined: GLP-1 Receptor Endogenous cell membrane interactome mapping

Byetta SPC (accessed May 2013) 19.Novo Nordisk

Guidelines recommend GLP-1 agents with proven cardiovascular benefit for patients with type 2 diabetes and atherosclerotic cardiovascular disease

We included costs of lost earnings due to absenteeism (acute and chronic), workforce dropout due to CVD or ESKD, and loss of future earnings from premature mortality (death before retirement age, which was set at 67 years)

Peptides are notoriously difficult to deliver orally because they are degraded by gastric acid and proteolytic enzymes in the GI tract

However, given the neutral effect of GLP-1 RAs on surrogate HF outcomes in HFrEF and a potentially increased risk of arrhythmias and HF-related hospitalisations, conducting further large-scale trials in the HFrEF cohort seems complicated